Review article · 2013
Conference abstractPublished 28 Sep 2015
The relevance of some molecular markers in recurrent pancreatic cancer: Focusing on CA 19-9 and cytokeratins
1University of Medicine and Pharmacy âÂ?Â?Gr.T.PopaâÂ? Iasi, Romania 2University of Medicine and Pharmacy of Cluj, Romania 3University of Medicine and Pharmacy of Craiova, Romania 4Alexandru Ioan CuzaâÂ? University, Iasi, Rom
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lately it is generally believed that the incidence of pancreatic neoplasm has increased exponentially all over the world, and especially in the last decade, by even becoming the fifth cause of death by cancer. However, the vast majority of the patients present to the clinic in the advanced unresectable stages, while significant risk factors for pancreatic cancer are still insufficiently studied. In addition, when it comes to the recurrence of the pancreatic cancer, there are also many unknowns regarding the mechanisms and the factors which are implicated. In this way, in this report we want it to make a concise description and analysis for the relevance of some molecular factors in recurrent pancreatic cancer, by mainly focusing on CA19-9 and cytokeratins, besides the other classical clinical factors which are relevant in the diagnostic of the pancreatic cancer recurrence.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Case report · 14 Nov 2015
Prostate-Specific Membrane Antigen-Radioguided Salvage Hemiablation High Intensity Focused Ultrasound for Radio-Recurrent Prostate Cancer
Research article · 26 Mar 2021
Evaluation of selected proinflammatory factors, angiogenesis and lymphangiogenesis as potential markers of early tumor recurrence in patients undergoing surgical treatment for prostate cancer
Research article · 2014
β-Tubulin is a Predictive Marker of Docetaxel Combined with S-1 in Recurrent or Metastatic Gastric Cancer
Research article · 2014
andbeta;-Tubulin is a Predictive Marker of Docetaxel Combined with S-1 in Recurrent or Metastatic Gastric Cancer
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Alin Ciobica”
- BylineArticles whose byline prints “Daniel Timofte”
- BylineArticles whose byline prints “Vasile Bintintan”
- BylineArticles whose byline prints “Valeriu Surlin”
- BylineArticles whose byline prints “Emil Anton”
- BylineArticles whose byline prints “Mihaela Blaj”

